Alliancebernstein L.P. Teva Pharmaceutical Industries LTD Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Alliancebernstein L.P. holds 218,535 shares of TEVA stock, worth $3.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

218,535

Previous 215,734 1.3%

Holding current value

$3.74 Million

Previous $3.04 Million 16.66%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $35,796 - $48,737	2,801 Added 1.3%	218,535 $3.55 Million
Q1 2024 May 14, 2024	SELL	$10.67 - $14.43 $27,368 - $37,012	-2,565 Reduced 1.17%	215,734 $3.04 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $73,835 - $96,658	-9,093 Reduced 4.0%	218,299 $2.28 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $61,597 - $88,114	-8,235 Reduced 3.49%	227,392 $2.32 Million
Q2 2023 Aug 15, 2023	SELL	$7.2 - $9.47 $15,969 - $21,004	-2,218 Reduced 0.93%	235,627 $1.77 Million
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $85,907 - $116,838	-10,276 Reduced 4.14%	237,845 $2.1 Million
Q4 2022 Feb 14, 2023	SELL	$7.95 - $9.48 $107,404 - $128,074	-13,510 Reduced 5.16%	248,121 $2.26 Million
Q3 2022 Nov 15, 2022	BUY	$6.86 - $11.95 $27,892 - $48,588	4,066 Added 1.58%	261,631 $2.11 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $7,306 - $10,296	990 Added 0.39%	257,565 $1.94 Million
Q1 2022 May 13, 2022	SELL	$7.33 - $9.39 $3.03 Million - $3.88 Million	-413,407 Reduced 61.7%	256,575 $2.41 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $3.06 Million - $3.95 Million	387,389 Added 137.08%	669,982 $5.37 Million
Q3 2021 Nov 10, 2021	SELL	$8.38 - $10.18 $5,958 - $7,237	-711 Reduced 0.25%	282,593 $2.75 Million
Q2 2021 Jul 30, 2021	SELL	$9.9 - $11.56 $73,378 - $85,682	-7,412 Reduced 2.55%	283,304 $2.81 Million
Q1 2021 May 06, 2021	SELL	$10.34 - $12.81 $87,497 - $108,398	-8,462 Reduced 2.83%	290,716 $3.36 Million
Q4 2020 Feb 08, 2021	SELL	$8.61 - $11.04 $261,167 - $334,876	-30,333 Reduced 9.21%	299,178 $2.89 Million
Q3 2020 Nov 12, 2020	BUY	$8.57 - $12.69 $50,588 - $74,909	5,903 Added 1.82%	329,511 $2.97 Million
Q2 2020 Aug 13, 2020	SELL	$8.12 - $13.12 $395,151 - $638,471	-48,664 Reduced 13.07%	323,608 $3.99 Million
Q1 2020 May 14, 2020	BUY	$6.69 - $13.45 $222,977 - $448,288	33,330 Added 9.83%	372,272 $3.34 Million
Q4 2019 Feb 18, 2020	SELL	$6.53 - $10.72 $6,575 - $10,795	-1,007 Reduced 0.3%	338,942 $3.32 Million
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $41.2 Million - $64.2 Million	-6,686,351 Reduced 95.16%	339,949 $2.34 Million
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $47.7 Million - $92.4 Million	-5,878,746 Reduced 45.55%	7,026,300 $64.9 Million
Q1 2019 May 14, 2019	BUY	$15.58 - $20.01 $56.7 Million - $72.8 Million	3,638,152 Added 39.26%	12,905,046 $202 Million
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $2.74 Million - $4.48 Million	-187,945 Reduced 1.99%	9,266,894 $143 Million
Q3 2018 Nov 08, 2018	BUY	$21.06 - $25.65 $48.3 Million - $58.8 Million	2,291,171 Added 31.98%	9,454,839 $204 Million
Q2 2018 Aug 13, 2018	SELL	$16.77 - $24.71 $3.17 Million - $4.67 Million	-188,839 Reduced 2.57%	7,163,668 $174 Million
Q1 2018 May 14, 2018	SELL	$16.68 - $22.07 $2.4 Million - $3.17 Million	-143,652 Reduced 1.92%	7,352,507 $126 Million
Q4 2017 Feb 13, 2018	SELL	$11.23 - $19.1 $56.8 Million - $96.6 Million	-5,058,097 Reduced 40.29%	7,496,159 $142 Million
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $193 Million - $404 Million	12,554,256	12,554,256 $221 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

565M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Teva Pharmaceutical Industries LTD Transaction History